News | June 21, 2023
Mandaviya inaugurates G20 co-branded event of PMNCH, Geneva on health
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Granules now has a total of 58 ANDA approvals from US FDA
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Subscribe To Our Newsletter & Stay Updated
